Cargando…

Genetic Analysis of PARK2 and PINK1 Genes in Brazilian Patients with Early-Onset Parkinson's Disease

Parkinson's disease is the second most frequent neurodegenerative disorder in the world, affecting 1-2% of individuals over the age of 65. The etiology of Parkinson's disease is complex, with the involvement of gene-environment interactions. Although it is considered a disease of late mani...

Descripción completa

Detalles Bibliográficos
Autores principales: Moura, Karla Cristina Vasconcelos, Campos Junior, Mário, de Rosso, Ana Lúcia Zuma, Nicaretta, Denise Hack, Pereira, João Santos, Silva, Delson José, dos Santos, Flávia Lima, Rodrigues, Fabíola da Costa, Santos-Rebouças, Cíntia Barros, Pimentel, Márcia Mattos Gonçalves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774967/
https://www.ncbi.nlm.nih.gov/pubmed/24167364
http://dx.doi.org/10.1155/2013/597158
_version_ 1782284550647316480
author Moura, Karla Cristina Vasconcelos
Campos Junior, Mário
de Rosso, Ana Lúcia Zuma
Nicaretta, Denise Hack
Pereira, João Santos
Silva, Delson José
dos Santos, Flávia Lima
Rodrigues, Fabíola da Costa
Santos-Rebouças, Cíntia Barros
Pimentel, Márcia Mattos Gonçalves
author_facet Moura, Karla Cristina Vasconcelos
Campos Junior, Mário
de Rosso, Ana Lúcia Zuma
Nicaretta, Denise Hack
Pereira, João Santos
Silva, Delson José
dos Santos, Flávia Lima
Rodrigues, Fabíola da Costa
Santos-Rebouças, Cíntia Barros
Pimentel, Márcia Mattos Gonçalves
author_sort Moura, Karla Cristina Vasconcelos
collection PubMed
description Parkinson's disease is the second most frequent neurodegenerative disorder in the world, affecting 1-2% of individuals over the age of 65. The etiology of Parkinson's disease is complex, with the involvement of gene-environment interactions. Although it is considered a disease of late manifestation, early-onset forms of parkinsonism contribute to 5–10% of all cases. In the present study, we screened mutations in coding regions of PARK2 and PINK1 genes in 136 unrelated Brazilian patients with early-onset Parkinson's disease through automatic sequencing. We identified six missense variants in PARK2 gene: one known pathogenic mutation, two variants of uncertain role, and three nonpathogenic changes. No pathogenic mutation was identified in PINK1 gene, only benign polymorphisms. All putative pathogenic variants found in this study were in heterozygous state. Our data show that PARK2 point mutations are more common in Brazilian early-onset Parkinson's disease patients (2.9%) than PINK1 missense variants (0%), corroborating other studies worldwide.
format Online
Article
Text
id pubmed-3774967
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37749672013-10-01 Genetic Analysis of PARK2 and PINK1 Genes in Brazilian Patients with Early-Onset Parkinson's Disease Moura, Karla Cristina Vasconcelos Campos Junior, Mário de Rosso, Ana Lúcia Zuma Nicaretta, Denise Hack Pereira, João Santos Silva, Delson José dos Santos, Flávia Lima Rodrigues, Fabíola da Costa Santos-Rebouças, Cíntia Barros Pimentel, Márcia Mattos Gonçalves Dis Markers Research Article Parkinson's disease is the second most frequent neurodegenerative disorder in the world, affecting 1-2% of individuals over the age of 65. The etiology of Parkinson's disease is complex, with the involvement of gene-environment interactions. Although it is considered a disease of late manifestation, early-onset forms of parkinsonism contribute to 5–10% of all cases. In the present study, we screened mutations in coding regions of PARK2 and PINK1 genes in 136 unrelated Brazilian patients with early-onset Parkinson's disease through automatic sequencing. We identified six missense variants in PARK2 gene: one known pathogenic mutation, two variants of uncertain role, and three nonpathogenic changes. No pathogenic mutation was identified in PINK1 gene, only benign polymorphisms. All putative pathogenic variants found in this study were in heterozygous state. Our data show that PARK2 point mutations are more common in Brazilian early-onset Parkinson's disease patients (2.9%) than PINK1 missense variants (0%), corroborating other studies worldwide. Hindawi Publishing Corporation 2013 2013-08-14 /pmc/articles/PMC3774967/ /pubmed/24167364 http://dx.doi.org/10.1155/2013/597158 Text en Copyright © 2013 Karla Cristina Vasconcelos Moura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Moura, Karla Cristina Vasconcelos
Campos Junior, Mário
de Rosso, Ana Lúcia Zuma
Nicaretta, Denise Hack
Pereira, João Santos
Silva, Delson José
dos Santos, Flávia Lima
Rodrigues, Fabíola da Costa
Santos-Rebouças, Cíntia Barros
Pimentel, Márcia Mattos Gonçalves
Genetic Analysis of PARK2 and PINK1 Genes in Brazilian Patients with Early-Onset Parkinson's Disease
title Genetic Analysis of PARK2 and PINK1 Genes in Brazilian Patients with Early-Onset Parkinson's Disease
title_full Genetic Analysis of PARK2 and PINK1 Genes in Brazilian Patients with Early-Onset Parkinson's Disease
title_fullStr Genetic Analysis of PARK2 and PINK1 Genes in Brazilian Patients with Early-Onset Parkinson's Disease
title_full_unstemmed Genetic Analysis of PARK2 and PINK1 Genes in Brazilian Patients with Early-Onset Parkinson's Disease
title_short Genetic Analysis of PARK2 and PINK1 Genes in Brazilian Patients with Early-Onset Parkinson's Disease
title_sort genetic analysis of park2 and pink1 genes in brazilian patients with early-onset parkinson's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774967/
https://www.ncbi.nlm.nih.gov/pubmed/24167364
http://dx.doi.org/10.1155/2013/597158
work_keys_str_mv AT mourakarlacristinavasconcelos geneticanalysisofpark2andpink1genesinbrazilianpatientswithearlyonsetparkinsonsdisease
AT camposjuniormario geneticanalysisofpark2andpink1genesinbrazilianpatientswithearlyonsetparkinsonsdisease
AT derossoanaluciazuma geneticanalysisofpark2andpink1genesinbrazilianpatientswithearlyonsetparkinsonsdisease
AT nicarettadenisehack geneticanalysisofpark2andpink1genesinbrazilianpatientswithearlyonsetparkinsonsdisease
AT pereirajoaosantos geneticanalysisofpark2andpink1genesinbrazilianpatientswithearlyonsetparkinsonsdisease
AT silvadelsonjose geneticanalysisofpark2andpink1genesinbrazilianpatientswithearlyonsetparkinsonsdisease
AT dossantosflavialima geneticanalysisofpark2andpink1genesinbrazilianpatientswithearlyonsetparkinsonsdisease
AT rodriguesfabioladacosta geneticanalysisofpark2andpink1genesinbrazilianpatientswithearlyonsetparkinsonsdisease
AT santosreboucascintiabarros geneticanalysisofpark2andpink1genesinbrazilianpatientswithearlyonsetparkinsonsdisease
AT pimentelmarciamattosgoncalves geneticanalysisofpark2andpink1genesinbrazilianpatientswithearlyonsetparkinsonsdisease